M.V.I. Pediatric (Hospira, Inc.)
Welcome to the PulseAid listing for the M.V.I. Pediatric drug offered from Hospira, Inc.. This Ergocalciferols [Chemical/Ingredient],Provitamin D2 Compound [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Increased Prothrombin Activity [PE],Reversed Anticoagulation Activity [PE],Vitamin K [Chemical/Ingredient],Vitamin K [EPC],Warfarin Reversal Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | ascorbic acid, retinol, ergocalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, .alpha.-tocopherol acetate, dl-, biotin, folic acid, |
| SUBSTANCE NAME: | ASCORBIC ACID; RETINOL; ERGOCALCIFEROL; THIAMINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; PYRIDOXINE HYDROCHLORIDE; NIACINAMIDE; DEXPANTHENOL; .ALPHA.-TOCOPHEROL ACETATE, DL-; BIOTIN; FOLIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ergocalciferols [Chemical/Ingredient],Provitamin D2 Compound [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Increased Prothrombin Activity [PE],Reversed Anticoagulation Activity [PE],Vitamin K [Chemical/Ingredient],Vitamin K [EPC],Warfarin Reversal Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-07-01 |
| END MARKETING DATE: | 0000-00-00 |
M.V.I. Pediatric HUMAN PRESCRIPTION DRUG Details:
| Item Description | M.V.I. Pediatric from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 80; .7; 10; 1.2; 1.4; 1; 17; 5; 7; 20; 140; 1; 200(mg/5mL; mg/5mL; ug/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; mg/5mL; ug/5mL; ug/5mL; ug/5mL; ug/5mL) |
| START MARKETING DATE: | 2006-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-421_91e23adb-0710-40f7-b25f-eb97e41ae45d |
| PRODUCT NDC: | 61703-421 |
| APPLICATION NUMBER: | NDA018920 |
Other ASCORBIC ACID; RETINOL; ERGOCALCIFEROL; THIAMINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; PYRIDOXINE HYDROCHLORIDE; NIACINAMIDE; DEXPANTHENOL; .ALPHA.-TOCOPHEROL ACETATE, DL-; BIOTIN; FOLIC ACID Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
